CoChat

GPCRomics: An Approach to Discover GPCR Drug Targets

Open access
Insel, Paul A., Sriram, Krishna, Gorr, Matthew W., Wiley, Shu Z., Michkov, Alexander, Salmerón, Cristina, Chinn, Amy M. · 2019 · Trends in Pharmacological Sciences
Cited by 178

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

G protein-coupled receptors (GPCRs) are targets for ~35% of approved drugs but only ~15% of the ~800 human GPCRs are currently such targets. GPCRomics, the use of unbiased, hypothesis-generating methods (e.g., RNA-sequencing [RNA-seq]), with tissues and cell types to identify and quantify GPCR expression, has led to the discovery of previously unrecognized GPCRs that contribute to functional responses and pathophysiology and that may be therapeutic targets. The combination of GPCR expression data with validation studies (e.g., signaling and functional activities) provides opportunities for the discovery of disease-relevant GPCR targets and therapeutics. Here, we review insights from GPCRomic approaches, gaps in knowledge and future directions by which GPCRomics can advance GPCR biology and the discovery of new GPCR-targeted drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tips.2019.04.001

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 71

  1. Milligan, 2018, G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35, Br. J. Pharmacol., 175, 2543, 10.1111/bph.14042 · DOI
  2. Insel, 2015, G protein-coupled receptor (GPCR) expression in native cells: “novel” endoGPCRs as physiologic regulators and therapeutic targets, Mol. Pharmacol., 88, 181, 10.1124/mol.115.098129 · DOI
  3. Ahlquist, 1948, A study of the adrenotropic receptors, Am. J. Physiol., 153, 586, 10.1152/ajplegacy.1948.153.3.586 · DOI · Paper page
  4. Wu, 2017, Structure and function of peptide-binding G protein-coupled receptors, J. Mol. Biol., 429, 2726, 10.1016/j.jmb.2017.06.022 · DOI
  5. Vass, 2018, Chemical diversity in the G protein-coupled receptor superfamily, Trends Pharmacol. Sci., 39, 494, 10.1016/j.tips.2018.02.004 · DOI
  6. Thal, 2018, Recent advances in the determination of G protein-coupled receptor structures, Curr. Opin. Struct. Biol., 51, 28, 10.1016/j.sbi.2018.03.002 · DOI
  7. Manglik, 2017, Structural basis for G protein-coupled receptor activation, Biochemistry, 56, 5628, 10.1021/acs.biochem.7b00747 · DOI · Paper page
  8. Thal, 2018, Structural insights into G-protein-coupled receptor allostery, Nature, 559, 45, 10.1038/s41586-018-0259-z · DOI · Paper page
  9. Munk, 2019, An online resource for GPCR structure determination and analysis, Nat. Methods, 16, 151, 10.1038/s41592-018-0302-x · DOI
  10. Wootten, 2018, Mechanisms of signalling and biased agonism in G protein-coupled receptors, Nat. Rev. Mol. Cell Biol., 19, 638, 10.1038/s41580-018-0049-3 · DOI · Paper page
  11. Smith, 2018, Biased signalling: from simple switches to allosteric microprocessors, Nat. Rev. Drug Discov., 17, 243, 10.1038/nrd.2017.229 · DOI · Paper page
  12. Milligan, 2019, GPCR homo-oligomerization, Curr. Opin. Cell Biol., 57, 40, 10.1016/j.ceb.2018.10.007 · DOI · Paper page
  13. Gurevich, 2018, GPCRs and signal transducers: interaction stoichiometry, Trends Pharmacol. Sci., 39, 672, 10.1016/j.tips.2018.04.002 · DOI
  14. Weinberg, 2018, Regulation of G protein-coupled receptor signaling by plasma membrane organization and endocytosis, Traffic, 20, 121, 10.1111/tra.12628 · DOI
  15. Maiga, 2016, Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets, Blood Cancer J., 6, 10.1038/bcj.2016.36 · DOI
  16. Koyama, 2016, Comprehensive profiling of GPCR expression in ghrelin-producing cells, Endocrinology, 157, 692, 10.1210/en.2015-1784 · DOI
  17. Amisten, S. (2016) Quantification of the mRNA expression of G protein-coupled receptors in human adipose tissue. In G Protein-Coupled Receptors (Vol. 132) (Shukla, K., ed.), pp. 73–105, Academic Press. · DOI
  18. Flegel, 2016, Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18, Sci. Rep., 6, 32255, 10.1038/srep32255 · DOI
  19. Liang, 2016, Gene expression profiling reveals different molecular patterns in G-protein coupled receptor signaling pathways between early- and late-onset preeclampsia, Placenta, 40, 52, 10.1016/j.placenta.2016.02.015 · DOI
  20. Balenga, 2017, Orphan adhesion GPCR GPR64/ADGRG2 is overexpressed in parathyroid tumors and attenuates calcium-sensing receptor-mediated signaling, J. Bone Miner. Res., 32, 654, 10.1002/jbmr.3023 · doi:10.1002/jbmr.3023
  21. Amisten, 2017, A comparative analysis of human and mouse islet G-protein coupled receptor expression, Sci. Rep., 7, 46600, 10.1038/srep46600 · DOI
  22. Bhat, 2018, GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer, Breast Cancer Res. Treat., 170, 279, 10.1007/s10549-018-4751-9 · DOI
  23. Roberts, 2018, The inhibition of human lung fibroblast proliferation and differentiation by Gs-coupled receptors is not predicted by the magnitude of cAMP response, Respir. Res., 19, 56, 10.1186/s12931-018-0759-2 · DOI
  24. Kübler, 2018, Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines, Oncotarget, 9, 24882, 10.18632/oncotarget.25427 · DOI
  25. Ehrlich, 2018, Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research, Commun. Biol., 1, 102, 10.1038/s42003-018-0106-7 · DOI · Paper page
  26. Flegel, 2015, RNA-seq analysis of human trigeminal and dorsal root ganglia with a focus on chemoreceptors, PLoS One, 10, 10.1371/journal.pone.0128951 · DOI · Paper page
  27. Ray, 2018, Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq–based resource for pain and sensory neuroscience research, Pain, 159, 1325, 10.1097/j.pain.0000000000001217 · DOI · Paper page
  28. Insel, 2018, GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets, Front. Pharmacol., 9, 431, 10.3389/fphar.2018.00431 · DOI
  29. Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
  30. Ogata, 1999, KEGG: Kyoto encyclopedia of genes and genomes, Nucleic Acids Res., 27, 29, 10.1093/nar/27.1.29 · DOI · Paper page
  31. Piltonen, 2018, Alternative splicing of the delta-opioid receptor gene suggests existence of new functional isoforms, Mol. Neurobiol.
  32. Markovic, 2009, Alternative splicing of G protein-coupled receptors: physiology and pathophysiology, Cell. Mol. Life Sci., 66, 3337, 10.1007/s00018-009-0093-4 · DOI
  33. Harding, 2018, The IUPHAR/BPS guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology, Nucleic Acids Res., 46, D1091, 10.1093/nar/gkx1121 · DOI · Paper page
  34. Snead, 2012, Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts, FASEB J., 26, 4540, 10.1096/fj.12-213496 · DOI
  35. Walker, 2015, A second trigeminal CGRP receptor: function and expression of the AMY 1 receptor, Ann. Clin. Transl. Neurol., 2, 595, 10.1002/acn3.197 · DOI · Paper page
  36. Jung, 2016, Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation, FASEB J., 30, 1464, 10.1096/fj.15-280982 · DOI
  37. Klepac, 2016, The Gq signalling pathway inhibits brown and beige adipose tissue, Nat. Commun., 7, 10895, 10.1038/ncomms10895 · DOI
  38. Wiley, 2018, GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells, FASEB J., 32, 1170, 10.1096/fj.201700834R · DOI · Paper page
  39. Mukherjee, 2019, Prostaglandin E2 inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca2+ signaling, Am. J. Physiol. Lung Cell Mol. Physiol., 316, L810, 10.1152/ajplung.00403.2018 · DOI
  40. Spaethling, 2016, Single-cell transcriptomics and functional target validation of brown adipocytes show their complex roles in metabolic homeostasis, FASEB J., 30, 81, 10.1096/fj.15-273797 · DOI · Paper page
  41. Spaethling, 2014, Serotonergic neuron regulation informed by in vivo single-cell transcriptomics, FASEB J., 28, 771, 10.1096/fj.13-240267 · DOI · Paper page
  42. Tischner, 2017, Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation, JCI Insight, 2, 95063, 10.1172/jci.insight.95063 · DOI
  43. Kaur, 2017, Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system, Nat. Commun., 8, 15700, 10.1038/ncomms15700 · DOI · Paper page
  44. Koussounadis, 2015, Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system, Sci. Rep., 5, 10775, 10.1038/srep10775 · DOI · Paper page
  45. Edfors, 2016, Gene-specific correlation of RNA and protein levels in human cells and tissues, Mol. Syst. Biol., 12, 883, 10.15252/msb.20167144 · DOI · Paper page
  46. Beermann, 2012, Commercially available antibodies against human and murine histamine H4-receptor lack specificity, Naunyn. Schmiedebergs. Arch. Pharmacol., 385, 125, 10.1007/s00210-011-0700-4 · DOI
  47. Marchalant, 2014, Validating antibodies to the cannabinoid CB2 receptor, J. Histochem. Cytochem., 62, 395, 10.1369/0022155414530995 · DOI · Paper page
  48. Liu, 2018, In vivo brain GPCR signaling elucidated by phosphoproteomics, Science, 360, 10.1126/science.aao4927 · DOI · Paper page
  49. Xiao, 2018, Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics, Cell Signal., 41, 56, 10.1016/j.cellsig.2017.09.013 · DOI
  50. Mincarelli, 2018, Defining cell identity with single-cell omics, Proteomics, 18, 10.1002/pmic.201700312 · DOI
  51. Tréfier, 2018, Investigation methods to explore G protein-coupled receptor-regulated translatome, C. R. Biol., 341, 65, 10.1016/j.crvi.2017.12.002 · DOI
  52. Atwood, 2011, Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis, BMC Genomics, 12, 18, 10.1186/1471-2164-12-14 · DOI · Paper page
  53. Aust, 2016, Adhesion GPCRs in tumorigenesis, Handb. Exp. Pharmacol., 234, 369, 10.1007/978-3-319-41523-9_17 · DOI
  54. Nohata, 2017, Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer, J. Hum. Genet., 62, 87, 10.1038/jhg.2016.124 · DOI
  55. Moody, 2018, Neuropeptide G protein-coupled receptors as oncotargets, Front. Endocrinol. (Lausanne), 9, 345, 10.3389/fendo.2018.00345 · DOI
  56. Ma, 2018, Application of nanoparticles for targeting G protein-coupled receptors, Int. J. Mol. Sci., 19, E2006, 10.3390/ijms19072006 · doi:10.3390/ijms19072006
  57. Zeng, 2018, Frizzled receptors as potential therapeutic targets in human cancers, Int. J. Mol. Sci., 19, E1543, 10.3390/ijms19051543 · DOI
  58. Nieto Gutierrez, 2018, GPCRs: emerging anti-cancer drug targets, Cell Signal., 41, 65, 10.1016/j.cellsig.2017.09.005 · DOI · Paper page
  59. Nugent, 2017, The role of G protein-coupled receptors in lymphoid malignancies, Cell Signal., 39, 95, 10.1016/j.cellsig.2017.08.002 · doi:10.1016/j.cellsig.2017.08.002
  60. Masuho, 2015, Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors, Sci. Signal., 8, ra123, 10.1126/scisignal.aab4068 · DOI · Paper page
  61. Sokolina, 2017, Systematic protein-protein interaction mapping for clinically relevant human GPCRs, Mol. Syst. Biol., 13, 918, 10.15252/msb.20167430 · DOI · Paper page
  62. Atanes, 2018, Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets, Cell. Mol. Life Sci., 75, 3039, 10.1007/s00018-018-2778-z · DOI
  63. Crépieux, 2017, A comprehensive view of the β-arrestinome, Front. Endocrinol. (Lausanne), 8, 32, 10.3389/fendo.2017.00032 · DOI
  64. Nag, 2018, Transcriptional landscape of PARs in epithelial malignancies, Int. J. Mol. Sci., 19, 3451, 10.3390/ijms19113451 · DOI
  65. Itcho, 2018, Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma, Mol. Cell. Endocrinol., 461, 100, 10.1016/j.mce.2017.08.019 · DOI
  66. Law, 2017, Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology, Am. J. Physiol. Gastrointest. Liver Physiol., 313, G361, 10.1152/ajpgi.00144.2017 · DOI
  67. Cazorla-Vázquez, 2018, Adhesion GPCRs in kidney development and disease, Front. Cell Dev. Biol., 6, 9, 10.3389/fcell.2018.00009 · DOI
  68. Jiang, 2018, GPRC5A: an emerging biomarker in human cancer, Biomed. Res. Int., 2018, 1
  69. Matters, 2018, Utilizing peptide ligand GPCRs to image and treat pancreatic cancer, Biomedicines, 6, E65, 10.3390/biomedicines6020065 · DOI
  70. Medapati, M.R. et al. (2017) Characterization of GPCRs in extracellular vesicle (EV). In G Protein-Coupled Receptors Part A (Vol. 142) (Shukla, K.., ed.), pp. 119–132, Academic Press. · DOI
  71. El Buri, 2018, The sphingosine 1-phosphate receptor 2 is shed in exosomes from breast cancer cells and is N-terminally processed to a short constitutively active form that promotes extracellular signal regulated kinase activation and DNA synthesis in fibroblasts, Oncotarget, 9, 29453, 10.18632/oncotarget.25658 · DOI

Cited by

See all 178

Metadata

Authors
Insel, P. A., Sriram, K., Gorr, M. W., Wiley, S. Z., Michkov, A., Salmerón, C., & Chinn, A. M.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2019-06
Volume
40
Issue
6
Pages
378-387
ISSN
0165-6147 (ISSN-L)
OpenAlex
W2944441714
Cited by
178
References
16
FWCI
1.69
Type
journal article
Language
en
Open access
bronze
Funders
  • National Institute of Health (HL098062, GM007752, CA121938, HL007444, CA189477, AG053568)
  • Department of Defense (W81XWH-14-1-0372)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.